Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Common Stock Issued (2023 - 2026)

Updated

Genmab A's Common Stock Issued was $1 million in the quarter ended Jun 30, 2026, down 50.0% from the prior quarter.

Analysis

Genmab A (GMAB) Common Stock Issued (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Genmab A's Common Stock Issued was $13 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was $23 million, up 21.1% from the prior year.

  • In earlier years, Common Stock Issued was $19 million in the year ended Dec 31, 2024 (-9.5%) and $21 million in the year ended Dec 31, 2023.
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Common Stock Issued since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 743.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 87.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 13.00 Mn
Jun 30, 2026 1.00 Mn
Mar 31, 2026 2.00 Mn
Mar 31, 2025 1.00 Mn
Mar 31, 2024 9.00 Mn
Dec 31, 2023 -122.00 Mn
Mar 31, 2023 32.00 Mn
API Access

Genmab A Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=GMAB&period=max&api_key=YOUR_API_KEY